DCGO
Next earnings: Aug 6, 2026 · After close
Signal
Bearish Setup2
Price
1
Move-3.38%Selling pressure
Volume
1
Volume0.2× avgLight volume
Technical
1
RSIRSI 41Momentum negative
PRICE
Prev Close
0.59
Open
0.59
Day Range0.57 – 0.60
0.57
0.60
52W Range0.49 – 1.78
0.49
1.78
6% of range
VOLUME & SIZE
Avg Volume
995.7K
FUNDAMENTALS
P/E Ratio
-0.3x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
1.26
Market-like
Performance
1D
-3.38%
5D
-9.33%
1M
+7.75%
3M
-23.38%
6M
-46.63%
YTD
-34.94%
1Y
-59.21%
Best: 1M (+7.75%)Worst: 1Y (-59.21%)
Quick Read
TrendInsufficient MA data
Momentum
BEARISH
revenue -42% YoY
Valuation
FAIR
P/E not available
Health
MODERATE
CR 1.8 · FCF negative
Neutral
Key MetricsTTM
Market Cap$56.41M
Revenue TTM$301.71M
Net Income TTM-$187.76M
Free Cash Flow-$5.09T
Gross Margin29.5%
Net Margin-62.2%
Operating Margin-36.7%
Return on Equity-89.0%
Return on Assets-89.7%
Debt / Equity0.22
Current Ratio1.79
EPS TTM$-1.90
Alpha SignalsFull Analysis →
What Moves This Stock

Government contract wins or losses, particularly large municipal healthcare logistics agreements which can represent 10-20% of revenue

Insurance reimbursement rate changes from major payors like Medicare, Medicaid, and commercial insurers

Regulatory developments affecting mobile healthcare licensing, scope of practice for paramedics, or medical transportation requirements

Geographic expansion announcements and market entry execution, particularly in high-density urban markets

Macro Sensitivity
Economic Cycle

low - Healthcare utilization, particularly emergency medical services and chronic disease management, demonstrates counter-cyclical or acyclical characteristics as medical needs persist regardless of economic conditions. However, elective mobile health services and corporate wellness contracts show moderate sensitivity to business spending cycles. Government contract revenue is relatively stable but subject to municipal budget constraints during recessions.

Interest Rates

Rising interest rates have moderate negative impact through higher financing costs for fleet expansion and working capital facilities, though the company's low debt-to-equity ratio of 0.11 limits exposure. Rate increases also pressure valuation multiples for unprofitable growth companies, particularly relevant given negative ROE. However, the asset-light model relative to traditional healthcare facilities reduces capital intensity and rate sensitivity compared to hospital operators or skilled nursing facilities.

Key Risks

Regulatory risk from state-level medical transportation licensing requirements, scope of practice restrictions for paramedics providing non-emergency care, and potential federal oversight of remote patient monitoring reimbursement models

Labor market tightness for paramedics and EMTs driving wage inflation that cannot be fully passed through to payors, particularly acute in competitive urban markets

Technology disruption risk from hospital-at-home programs, autonomous medical vehicles, or AI-driven triage systems that could commoditize mobile healthcare coordination

Investor Profile

value - The extreme valuation dislocation (0.2x P/S, 0.3x P/B, 81% FCF yield) attracts deep value investors and distressed/special situations funds looking for turnaround opportunities or liquidation value. The 85% drawdown has likely flushed out growth investors. Current holders are likely contrarian value players betting on operational stabilization, asset sales, or takeout potential given the revenue base substantially exceeds market cap.

Watch on Earnings
Medicare and Medicaid reimbursement rate changes for ambulance services and remote patient monitoring codesState-level healthcare budget allocations and municipal spending on emergency medical servicesParamedic and EMT wage inflation trends in key operating markets (Northeast US, UK)Healthcare utilization rates including emergency department visits and hospital readmission rates that drive mobile health demand
Health Radar
2 strong1 watch3 concern
39/100
Liquidity
1.79Watch
Leverage
0.22Strong
Coverage
-160.9xConcern
ROE
-89.0%Concern
ROIC
-77.8%Concern
Cash
$51MStrong
ANALYST COVERAGE8 analysts
BUY
+849.9%upside to target
L $1.50
Med $5.43consensus
H $11.00
Buy
788%
Hold
113%
7 Buy (88%)1 Hold (13%)0 Sell (-1%)
Full report →
Stock Health
Composite Score
3 of 5 signals bullish
7/10
Technicals
RSI RangeRSI 41 — Bearish momentum
Volume
Volume FlowAccumulation — institutional buying
Fundamentals
Last EarningsMissed estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 1.79 — healthy liquidity
Upcoming Events
EEarnings ReportMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentAug 28, 2026
In 104 days
Technicals
Technical SetupBEARISH
Technicals →

Trend

DowntrendDeath Cross · 50D trails 200D by 38.1%

-17.5% vs SMA 50 · -48.9% vs SMA 200

Momentum

RSI41.1
Momentum fading
MACD-0.03
Below zero — bearish pulse · expanding
Market Position
Price Levels
52W High
$1.78+211.7%
EMA 200
$1.09+90.5%
EMA 50
$0.6940+21.5%
Current
$0.5711
52W Low
$0.4910-14.0%
52-Week RangeNear 52-week low
$0.49106th %ile$1.78
Squeeze SetupVolume-based
Moderate Squeeze Setup

Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.

20-Day Money Flow
Acc days:3
Dist days:0
Edge:+3 acc
Volume Context
Avg Vol (50D)1.1M
Recent Vol (5D)
591K-47%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 5 analysts
Analyst revisions:Revenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2023
$742.8M
$733.4M$751.8M
$0.29
±2%
Low2
FY2024
$625.1M
$623.0M$626.5M
-15.8%$0.25-13.0%
±6%
High5
FY2025
$317.5M
$316.9M$318.2M
-49.2%-$0.67
±31%
Moderate4
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryDCGO
Last 8Q
-141.3%avg beat
Beat 1 of 8 quartersMissed 6 Estimates falling
-12%
Q3'24
Q4'24
-20%
Q1'25
-184%
Q2'25
-10%
Q3'25
+26%
Q4'25
-430%
Q1'26
-500%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Analyst Activity
All ratings →
No recent activity
Deutsche BankHold
Feb 28
DOWNGRADE
Insider Activity
SEC Filings →
5 Buys/1 SellNet Buying
Tendler Ely DDir
$15K
Dec 15
SELL
Burdiek Michael JDir
$13K
May 23
BUY
Burdiek Michael JDir
$21K
May 15
BUY
Klasko Stephen K. M…Dir
$22K
May 14
BUY
Sugrue StephenChief Complian…
$14K
May 14
BUY
Rosenberg NormanCFO and Treasu…
$22K
May 14
BUY
Financials

INSTITUTIONAL OWNERSHIP

1
BlackRock, Inc.
6.4M
2
P.A.W. CAPITAL CORP
3.0M
3
Knott David M Jr
2.7M
4
CITADEL ADVISORS LLC
2.5M
5
GEODE CAPITAL MANAGEMENT, LLC
2.4M
6
S Squared Technology, LLC
2.1M
7
STATE STREET CORP
2.0M
8
ACADIAN ASSET MANAGEMENT LLC
1.5M
News & Activity

DCGO News

20 articles · 4h ago

About

DocGo is a leading provider of mobile medical services and transportation in 26 US States and in the United Kingdom.

CEO
Stan Vashovsky
Rosemarie MilanoVice President of Human Resources
Mike ColeVice President of Investor Relations
PeersHealth Care(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
DCGO
$0.57-3.38%$56M-4774.3%-5661.1%1500
$66.13-5.07%$13.0B+12626.1%-14525.8%1500
$94.92-3.79%$12.6B+3288.2%-4239.0%1500
$523.69-3.00%$12.1B+43205.3%-3008.0%1500
$227.72-1.30%$11.7B+6554.5%-2868.8%1500
$57.90-0.86%$11.2B50.3+1459.3%147.7%1500
$76.67-3.79%$10.8B+2325815.3%-19.7%1500
Sector avg-3.03%50.3+341167.8%-4310.7%1500